Letter to the Editors regarding 'A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis'.

Alcohol Alcohol

Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Meibergdreef 5, Amsterdam 1105AZ, The Netherlands.

Published: November 2023

Download full-text PDF

Source
http://dx.doi.org/10.1093/alcalc/agad065DOI Listing

Publication Analysis

Top Keywords

letter editors
4
editors meta-regression
4
meta-regression trial
4
trial features
4
features predicting
4
predicting effects
4
effects alcohol
4
alcohol disorder
4
disorder pharmacotherapies
4
pharmacotherapies drinking
4

Similar Publications

How does dopamine convert into norepinephrine? Insights on the key step of the reaction.

J Mol Model

January 2025

Laboratorio de Química Teórica Computacional (QTC), Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Avenida Vicuña Mackenna 4860, 7820436, Santiago de Chile, Chile.

Context: Dopamine -monooxygenase (D M) is an essential enzyme in the organism that regioselectively converts dopamine into R-norepinephrine, the key step of the reaction, studied in this paper, is a hydrogen atom transfer (HAT) from dopamine to a superoxo complex on D M, forming a hydroperoxo intermediate and dopamine radical. It was found that the formation of a hydrogen bond between dopamine and the D M catalyst strengthens the substrate-enzyme interaction and facilitates the HAT which takes place selectively to give the desired enantiomeric form of the product. Six reactions leading to the hydroperoxo intermediate were analyzed in detail using theoretical and computational tools in order to identify the most probable reaction mechanism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!